News

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

By December 12, 202242 views

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.